Levofloxacine Hikma

Levofloxacin, the active ingredient in Levofloxacine Hikma, is a fluoroquinolone presented as an unknown strength/unknown form for intravenous use. It treats a range of serious bacterial infections in adult patients. GNH USA supplies Levofloxacine Hikma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levofloxacine Hikma is a fluoroquinolone antibiotic indicated for several serious bacterial infections. - Community‑acquired pneumonia: eradicates the causative pathogens and improves respiratory function. - Complicated urinary tract infections: eliminates resistant Gram‑negative organisms and resolves infection. - Skin and soft tissue infections: reduces bacterial load and promotes healing of infected lesions. - Intra‑abdominal infections: provides broad‑spectrum coverage against mixed aerobic and anaerobic flora. - Bacterial prostatitis: penetrates prostatic tissue to treat chronic bacterial inflammation.

Levofloxacine Hikma may cause adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Rash: mild skin erythema or pruritus. - Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects: - Tendon rupture: sudden pain and loss of function, especially in the Achilles tendon. - QT interval prolongation: cardiac arrhythmia risk in susceptible patients. - Severe hypersensitivity: anaphylaxis, angioedema, or Stevens‑Johnson syndrome.

Levofloxacine Hikma requires careful consideration of patient‑specific factors before use. - Renal impairment: adjust therapy based on creatinine clearance. - History of tendon disorders: avoid in patients with prior tendon injury. - Cardiac risk: monitor ECG in patients with known QT prolongation. - Concomitant CNS stimulants: use caution as seizures may be precipitated. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Levofloxacine Hikma can affect or be affected by other medicines.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: markedly reduce levofloxacin absorption. - Warfarin: may increase anticoagulant effect and bleeding risk. - Cyclosporine: increased cyclosporine serum concentrations.

Moderate Interactions (Monitor Closely): - NSAIDs (e.g., ibuprofen): may increase risk of CNS stimulation and seizures. - Theophylline: potential for elevated plasma theophylline levels. - Corticosteroids: heightened risk of tendon rupture when combined.